|
|
| Line 1: |
Line 1: |
| | <html> | | <html> |
| − | <script>
| |
| | | | |
| − | var content_alpha = {
| + | <groupparts>iGEM19 Jilin_China</groupparts> |
| − | prospect:{
| + | |
| − | title:"Parts"
| + | |
| − | },
| + | |
| − | part: [{
| + | |
| − | title: "Overview",
| + | |
| − | para: [
| + | |
| | | | |
| − | {
| |
| − | type: "word",
| |
| − | cont: "This year, in order to achieve our goal of treating VVC by synthetic biology, Jilin_China has registered 16 basic parts and 21 composite parts according to the sensing system, therapeutical system and suicide system of engineered bacteria. You can see the brief introduction of all parts here. In addition, our best basic part and composite part are also introduced in detail here.",
| |
| − | //spClass:[["deprivation","strong"]],
| |
| − | //link:[["temperature","www.urlm.com.cn"]],
| |
| − | class: "np5"
| |
| − | },
| |
| − |
| |
| − | {
| |
| − | type: "word",
| |
| − | cont: "<groupparts>iGEM19 Jilin_China</groupparts>",
| |
| − | class: "np3"
| |
| − | },
| |
| − |
| |
| − | ]
| |
| − |
| |
| − | }]}
| |
| − |
| |
| − |
| |
| − |
| |
| − |
| |
| − |
| |
| − |
| |
| − |
| |
| − |
| |
| − |
| |
| − |
| |
| − |
| |
| − | </script>
| |
| | </html> | | </html> |
| − | {{:Team:Jilin_China/HXT8.0}}
| |
